Mobix Labs Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023
Net Income	-39.98	-46.13	-20.03	-39.62
Depreciation & Amortization	0.12	0.37	0.47	1.29
Stock-Based Compensation	20.06	25.62	0.02	15.48
Other Adjustments	7.08	7.77	1	3.59
Change in Receivables	0.83	1.43	-0	0.39
Changes in Inventories	-0.19	0.29	-0.11	0.25
Changes in Accounts Payable	-5.34	-1.28	0	1.39
Changes in Accrued Expenses	-2.04	0.92	2.85	2.32
Changes in Other Operating Activities	-0.31	0	0	0.3
Operating Cash Flow	-17.61	-10.11	-18.39	-14.63
Capital Expenditures	-0.01	-0.03	-0.04	-
Sale of Property, Plant & Equipment	-	0.03	-	-
Payments for Business Acquisitions	-	-	-0	-0.63
Investing Cash Flow	0.02	0	-0	-0.63
Long-Term Debt Issued	8.33	5.32	1.65	3.14
Long-Term Debt Repaid	-3.27	-0.58	-0	-1.46
Net Long-Term Debt Issued (Repaid)	5.06	4.74	1.64	1.68
Issuance of Common Stock	4.99	5.25	3.76	14.42
Net Common Stock Issued (Repurchased)	4.99	5.25	3.76	14.42
Other Financing Activities	-	-0.17	0.01	-0.93
Financing Cash Flow	19.38	13.12	19.67	15.17
Net Cash Flow	-1.22	0	0	-0.09
Free Cash Flow	-17.62	-10.14	-18.43	-14.63
FCF Margin	-749.96%	-102.29%	-286.12%	-1194.93%
Free Cash Flow Per Share	-2.66	-2.23	-6.25	-10.01
Levered Free Cash Flow	-30.68	-41.12	-15.21	-31.67
Unlevered Free Cash Flow	-37.92	-37.42	-43.21	-30

SEC Filings: 10-K · 10-Q